10/31/2022 9:08:31 AM
Wedbush Is Lowering Y-mAbs Therapeutics, Inc. (YMAB) FY23 Rev. Estimate To 73.0 M From 81.5 M
10/31/2022 9:07:49 AM
Wedbush Is Lowering Y-mAbs Therapeutics, Inc. (YMAB) Q4 23 Rev. Estimate To 21.1 M From 24.9 M
10/31/2022 9:07:28 AM
Wedbush Is Cutting Y-mAbs Therapeutics, Inc. (YMAB) Q3 23 Rev. Estimate To 19.7 M From 21.9 M
10/31/2022 9:07:03 AM
Wedbush Is Cutting Y-mAbs Therapeutics, Inc. (YMAB) Q2 23 Rev. Estimate To 17.4 M From 18.8 M
10/31/2022 9:05:20 AM
Wedbush Is Cutting Y-mAbs Therapeutics, Inc. (YMAB) Q1 23 Rev. Estimate To 14.7 M From 15.8 M
10/31/2022 9:02:47 AM
Wedbush Is Cutting Y-mAbs Therapeutics, Inc. (YMAB) Q4 22 Rev. Estimate To 26.5 M From 26.9 M
10/31/2022 9:01:53 AM
Wedbush Is Increasing Y-mAbs Therapeutics, Inc. (YMAB) FY23 Estimate To -2.10 From -2.85
10/31/2022 9:01:34 AM
Wedbush Is Raising Y-mAbs Therapeutics, Inc. (YMAB) Q4 23 Estimate To -0.41 From -0.60
10/31/2022 9:01:17 AM
Wedbush Is Increasing Y-mAbs Therapeutics, Inc. (YMAB) Q3 23 Estimate To -0.55 From -0.72
10/31/2022 9:01:03 AM
Wedbush Is Increasing Y-mAbs Therapeutics, Inc. (YMAB) Q2 23 Estimate To -0.56 From -0.75
10/31/2022 9:00:48 AM
Wedbush Is Raising Y-mAbs Therapeutics, Inc. (YMAB) Q1 23 Estimate To -0.58 From -0.78
10/31/2022 9:00:26 AM
Wedbush Is Increasing Y-mAbs Therapeutics, Inc. (YMAB) FY22 Estimate To -2.98 From -3.13
10/31/2022 8:59:06 AM
Wedbush Is Raising Y-mAbs Therapeutics, Inc. (YMAB) Q4 22 Estimate To -0.42 From -0.57
10/31/2022 8:58:19 AM
Wedbush Lowers Y-mAbs Therapeutics, Inc. (YMAB) To Neutral From Outperform With $6 Down From $21 Price Target
5/31/2022 11:26:25 AM
Wedbush Reiterates Y-mAbs Therapeutics, Inc. (YMAB) At Outperform With $21 Price Target